Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2017 · 10-Q
Revenue$130.58M$130.58M+16.2% vs Q1 2016 Net Income$18.84M$18.84M−17.0% vs Q1 2016 EPS Diluted$0.50$0.50−18.0% vs Q1 2016 Gross Profit$87,345,000+15.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$26,502,000−16.7% Free Cash Flowderived$24,060,000−6.4% Margins · derivedGross margin66.9%−0.2 pt vs Q1 2016
Operating margin22.3%−5.3 pt vs Q1 2016
Net margin14.4%−5.8 pt vs Q1 2016
ended Sep 30, 2016 · filed Nov 9, 2016 · 40 d after period end